CLOCK and colorectal cancer: Accumulating evidence suggests that the dysregulation of circadian clock gene expression including CLOCK1, CRY1, CRY2, and PER1–3 is associated with the increased incidence and metastasis of cancers such as colorectal cancer, breast cancer, and glioma [4–8].